Transgene Biotek

Quarterly
Consolidated
ParticularsJun '25Sep '25Dec '25Mar '26Jun '26
Revenue0.050.050.050.200.06
Expenses0.490.440.420.660.45
EBITDA-0.14-0.07-0.05-0.13-0.06
Operating Profit-0.18-0.13-0.10-0.18-0.10
Profit Before Tax-0.43-0.39-0.37-0.46-0.39
Net Profit-0.43-0.39-0.37-0.46-0.39
Financial Ratios
Operating Profit Margin-280.00%-140.00%-100.00%-260.00%-100.00%
Net Profit Margin-860.00%-780.00%-740.00%-920.00%-650.00%
Earning Per Share (Diluted)-0.06-0.05-0.05-0.06-0.05
Dividends Per Share0.000.000.000.000.00